... the city government, through the nonprofit San Antonio Economic Development Corp., actually investing public dollars in the bioscience business.
News
- Without independent oversight, San Antonio's city government will keep making the same mistakes
- Neurocrine: Q1 Earnings Snapshot
SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Wednesday reported first-quarter profit of $32.1 million. On a per-share basis, the San ...
- Fate Therapeutics: Q1 Earnings Snapshot
The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share. The clinical-stage biotech company ...
- US backs waiving intellectual property rules on vaccines
Dr. Michelle McMurry-Heath, chief executive of the Biotechnology Innovation Organization trade group, said in a statement that the decision will ...
- The Use of Artificial Intelligence in Healthcare Accelerated During the Pandemic. It's Here to Stay.
... solutions for population-health management, directly benefiting providers, health plans, employers and pharmaceutical and biotech organizations.